Withdrawal of Registration Statement (rw)
21 Agosto 2019 - 10:32PM
Edgar (US Regulatory)
PROPANC
BIOPHARMA, INC.
302,
6 Butler Street
Camberwell,
VIC, 3124 Australia
61
3 9882 0780
August
21, 2019
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street N.E.
Washington,
D.C. 20549
|
Re:
|
Propanc
Biopharma, Inc.
|
|
|
Request
for Withdrawal
|
|
|
Registration
Statement on Form S-1 (File No. 333-231682)
|
Ladies
and Gentlemen:
Propanc
Biopharma, Inc. (the “Company”) hereby requests the Company’s Registration Statement on Form S-1 (File No. 333-231682)
initially filed with the Securities and Exchange Commission (the “Commission”) on May 23, 2019, as subsequently amended
on June 14, 2019 (together with all exhibits thereto, the “Registration Statement”) be withdrawn. The Company confirms
that no securities were issued or sold pursuant to the Registration Statement.
The
Company has determined at this time not to proceed and requests that the Commission consent to this application on the grounds
that withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated
by paragraph (a) of Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”).
Accordingly,
pursuant to Rule 477 under the Securities Act, the Company hereby requests that the Registration Statement be withdrawn, effective
as of the date hereof or the earliest practicable date.
Should
you have any questions regarding this filing, please do not hesitate to contact the undersigned at +61 3 9882 0780.
|
Sincerely,
|
|
|
|
PROPANC
BIOPHARMA, INC.
|
|
|
|
By:
|
/s/
James Nathanielsz
|
|
Name:
|
James
Nathanielsz
|
|
Title:
|
Chief
Executive Officer
|
Grafico Azioni Propanc Biopharma (PK) (USOTC:PPCB)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Propanc Biopharma (PK) (USOTC:PPCB)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Propanc Biopharma Inc (PK) (OTCMarkets): 0 articoli recenti
Più Propanc Biopharma, Inc. Articoli Notizie